News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ClinTec GmbH CEO & President, Dr. Rabinder Buttar Receives Honorary Doctorate For Her Contribution To Life Sciences



7/9/2010 9:33:29 AM

Leading entrepreneur, Dr Rabinder Buttar, President & CEO of Clinical Research Organisation, ClinTec International has been officially honoured by the University of the West of Scotland with a Doctorate of the University (DUniv). This honorary doctorate was awarded in recognition Dr Buttar’s 20 years of contribution and achievements to the Life Sciences Industry and for the foundation and development of ClinTec International into an enterprising global company.

Professor Seamus McDaid, Principal and Vice Chancellor of the University of the West of Scotland, said: “We are delighted to award Dr Buttar with an Honorary Doctorate. As Chief Executive of ClinTec International, she is one of the country’s most important business leaders, making a hugely important contribution to the Scottish economy.”

The University of the West of Scotland is the biggest modern University in Scotland with almost 20,000 students. At the graduation ceremony which took place on Thursday 8 July in Paisley, Scotland, Dr Buttar joined the Court and Senate and addressed the Faculty of Science and Technology. In her address to the Faculty and its new Graduates, Dr Buttar said: "The University has created an exceptional pool of local and international graduates and I am honoured to come back here after 20 years and accept this degree. These graduates here today have successfully completed one chapter of their lives and as they open the next one their learning should never stop. In the current challenging times, graduates should seek local as well as global opportunities, look to do something they feel passionate about, be even more determined than ever before to succeed and then further success will be in their hands. The University and its excellent staff have prepared them well for the challenges that lie ahead. I feel honoured and privileged to join the Court and Senate today in recognizing and celebrating in some of Scotland’s academic achievements”.

This recognition by the University follows on from Dr Buttar’s other recent awards as the Ernst & Young Entrepreneur of the Year for Scotland and the Institute of Directors, Regional Director of the Year for the West of Scotland.

If you would like further information on ClinTec International, its CEO, Dr Rabinder Buttar, or details of the new offices and ClinTec’s Global Academy of Clinical Research Excellence (ACRE), please contact:

Bobby Bal, Senior Director, Corporate Development, Glasgow, Scotland, UK. Phone: +44 (0)141 226 1120 Fax: +44 (0)141 248 8993 Email : cdean@clintec.com

www.clintec.com

University of West of Scotland web link: http://www.uws.ac.uk/news/response-news Media Enquiries: Tristan Jervis or Alex Heeley Direct Tel: 00 44 207 861 3838 E-mail: t.jervis@defacto.com / a.heeley@defacto.com

About ClinTec International

ClinTec is a global contract clinical research organisation, established in 1997 by Dr Rabinder Buttar, the company’s President and CEO. ClinTec has a presence in over 40 developed and emerging countries across the globe.

ClinTec International’s clients include 11 of the top 25 pharmaceutical companies in the world and the company provides support in all aspects of clinical research to facilitate the development of innovative new medicines. To date, ClinTec has conducted over 250 international clinical trials in a vast range of therapeutic areas including oncology, cardiology, dermatology, gastroenterology, neurology, respiratory medicine and rheumatology.

ClinTec specialises in providing expert clinical research teams across the globe and its fast, flexible and focused approach is designed to enhance every clinical research aspect of the drug development process. The organisations services includes Clinical Monitoring, Project Management, Regulatory Affairs, Medical Writing, Data Management, Biostatistics, Global Clinical Resourcing, Quality Assurance, Drug Development Consultancy and Clinical Research Training.

For further information please contact: Bobby Bal, Senior Director Corporate Development, ClinTec International Headquarters: +44 (0) 141 226 1120 or bbal@clintec.com

For more information about ClinTec, please visit www.clintec.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES